Home

luk Ili kasnije Papua Nova Gvineja salomon stemmer satira u međuvremenu Koridor

Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Patients with cancer achieve response to messenger RNA COVID-19 vaccine

Health-related quality of life in patients with a germline BRCA mutation  and metastatic pancreatic cancer receiving maintenance olaparib -  ScienceDirect
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - ScienceDirect

First-of-its-kind study in Israel finds that cancer patients are safe for  COVID-19 vaccines - EJP
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP

Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of  Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction  Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer

Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with  primary brain tumors: a prospective cohort study | SpringerLink
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study | SpringerLink

Cetuximab intensifies cisplatin-induced testicular toxicity - ppt download
Cetuximab intensifies cisplatin-induced testicular toxicity - ppt download

OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of  Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this  video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" /  Twitter
OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / Twitter

Study: COVID-19 shots shown effective in cancer patients up to 4 months  later - UPI.com
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com

COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli  MDs | The Times of Israel
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel

Our Team – CTG-Pharma
Our Team – CTG-Pharma

UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna  Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and  Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for  being awarded
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who  were treated according to the Recurrence Score results: evidence from a  large prospectively designed registry | npj Breast Cancer
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer

Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver  Cancer Patients with Namodenoson | Business Wire
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors  - A Meta-Analysis and Systematic Review
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review

Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of  Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology

Transnational cancer research lab | Felsenstein Medical Research Center
Transnational cancer research lab | Felsenstein Medical Research Center

Can-Fite Initiates Compassionate Use Program for Namodenoson in the  Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire

Faculty | CoBrCa – Controversies in Breast Cancer
Faculty | CoBrCa – Controversies in Breast Cancer

מחקר תרגומי בסרטן
מחקר תרגומי בסרטן

Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of  Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology

Israel en Panamá - Con el tema "Innovation and Entrepreneurship in the  Health Care System" el Dr. Salomon Stemmer, Jefe de Investigación e  Innovación en el Instituto de Oncología del Centro Davidoff
Israel en Panamá - Con el tema "Innovation and Entrepreneurship in the Health Care System" el Dr. Salomon Stemmer, Jefe de Investigación e Innovación en el Instituto de Oncología del Centro Davidoff

Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of  Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology

Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase  Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian  Cancer: Systematic Review and Network Meta-Analysis
Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis

Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of  Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology

COVID vaccine effective for 90% of cancer patients, Israeli study finds |  The Times of Israel
COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel

Stemmer - List of Frontiers' open access articles
Stemmer - List of Frontiers' open access articles